Semaglutide is a new type of powerful hypoglycemic drug, which not only has a good hypoglycemic effect, but also has the effects of weight loss, blood pressure, and blood lipid improvement, and is one of the best-selling hypoglycemic drugs in the world.

At present, only semaglutide injection (pre-filled injection pen) is on the market in China, which is similar to insulin and needs to be injected subcutaneously, but it is not a substitute for insulin.

China's State Food and Drug Administration approved its indications for glycemic control in adult patients with type 2 diabetes mellitus, as well as to reduce the risk of major adverse cardiovascular events (cardiovascular death, non-fatal myocardial infarction or non-fatal stroke) in adult patients with type 2 diabetes mellitus with cardiovascular disease, but did not approve the indication of simple obesity.

Although semaglutide is used once a week, it needs to be injected subcutaneously, and the method of use and preservation is particular, for novices who use the drug for the first time, the following details need to be paid attention to in order to use it safely and effectively.

Semaglutide is a long-acting glucagon-like peptide-1 receptor agonist, which binds to the GLP-1 receptor and stimulates insulin synthesis and secretion in a glucose concentration-dependent manner, reducing glucagon secretion.

At the same time, it can also act on the GLP-1 receptor of the central nervous system, suppress appetite, reduce the amount of food eaten, delay the speed of food from the stomach to the small intestine, increase satiety, and thus achieve the effect of lowering blood sugar and weight loss.

The information is from the Internet and is for reference only.